- Home
- DIT vs CNTX Comparison
DIT vs CNTX Comparison
Compare DIT & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- CNTX
- Stock Information
- Founded
- DIT 1981
- CNTX 2015
- Country
- DIT United States
- CNTX United States
- Employees
- DIT N/A
- CNTX N/A
- Industry
- DIT Food Distributors
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- DIT Consumer Discretionary
- CNTX Health Care
- Exchange
- DIT Nasdaq
- CNTX Nasdaq
- Market Cap
- DIT 70.4M
- CNTX 78.0M
- IPO Year
- DIT 1995
- CNTX 2021
- Fundamental
- Price
- DIT $109.38
- CNTX $0.72
- Analyst Decision
- DIT
- CNTX Strong Buy
- Analyst Count
- DIT 0
- CNTX 5
- Target Price
- DIT N/A
- CNTX $5.25
- AVG Volume (30 Days)
- DIT 236.0
- CNTX 198.0K
- Earning Date
- DIT 07-18-2025
- CNTX 08-06-2025
- Dividend Yield
- DIT 0.91%
- CNTX N/A
- EPS Growth
- DIT N/A
- CNTX N/A
- EPS
- DIT 2.14
- CNTX N/A
- Revenue
- DIT $2,251,684,195.00
- CNTX N/A
- Revenue This Year
- DIT N/A
- CNTX N/A
- Revenue Next Year
- DIT N/A
- CNTX N/A
- P/E Ratio
- DIT $51.16
- CNTX N/A
- Revenue Growth
- DIT 7.64
- CNTX N/A
- 52 Week Low
- DIT $94.92
- CNTX $0.49
- 52 Week High
- DIT $163.75
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- DIT 45.97
- CNTX 46.79
- Support Level
- DIT $105.00
- CNTX $0.68
- Resistance Level
- DIT $109.66
- CNTX $0.84
- Average True Range (ATR)
- DIT 2.98
- CNTX 0.05
- MACD
- DIT -0.59
- CNTX -0.02
- Stochastic Oscillator
- DIT 44.83
- CNTX 21.85
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.